Cargando…
LncRNA HOXA-AS3 confers cisplatin resistance by interacting with HOXA3 in non-small-cell lung carcinoma cells
Many studies have indicated that the aberrant expression of long noncoding RNAs (lncRNAs) is responsible for drug resistance, which represents a substantial obstacle for cancer therapy. In the present study, we aimed to investigate the role of the lncRNA HOXA-AS3 in drug resistance and elucidate its...
Autores principales: | Lin, Shuang, Zhang, Rui, An, Xiaoxia, Li, Zhoubin, Fang, Cheng, Pan, Bo, Chen, Wei, Xu, Guodong, Han, Weili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794325/ https://www.ncbi.nlm.nih.gov/pubmed/31615976 http://dx.doi.org/10.1038/s41389-019-0170-y |
Ejemplares similares
-
Downregulated lncRNA HOXA11-AS Affects Trophoblast Cell Proliferation and Migration by Regulating RND3 and HOXA7 Expression in PE
por: Xu, Yetao, et al.
Publicado: (2018) -
The integrated comprehension of lncRNA HOXA-AS3 implication on human diseases
por: Yao, Qinfan, et al.
Publicado: (2022) -
HOXA11 antisense long noncoding RNA (HOXA11‐AS): A promising lncRNA in human cancers
por: Lu, Cheng‐Wei, et al.
Publicado: (2018) -
ARID1B/SUB1‐activated lncRNA HOXA‐AS2 drives the malignant behaviour of hepatoblastoma through regulation of HOXA3
por: Liu, Gongbao, et al.
Publicado: (2021) -
LncRNA PTCSC3 Alleviates the Postoperative Distant Recurrence of Gastric Cancer by Suppression of lncRNA HOXA11-AS
por: Xu, Jiapeng, et al.
Publicado: (2020)